申请人:Rito J. Christopher
公开号:US20050043337A1
公开(公告)日:2005-02-24
The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective β
3
receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and methods of treating Type II diabetes and obesity, comprising administering to a mammal in need thereof compounds of formula (I).
本发明涉及医学领域,特别是治疗II型糖尿病和肥胖症。更具体地,本发明涉及选择性β3受体激动剂,用于治疗II型糖尿病和肥胖症。本发明提供了化合物和治疗II型糖尿病和肥胖症的方法,包括向需要的哺乳动物施用式(I)的化合物。